Skip to content

SPectroscOpic Prediction of BRain Tumors: A Prospective Imaging Trial

SPectroscOpic Prediction of BRain Tumors: A Prospective Imaging Trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00019855
Enrollment
300
Registered
2020-01-14
Start date
2016-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9 D33.9

Interventions

Group 1: Pre-operative radiologic imaging, acquisition of genetic data of the tutor sample, histopathological diagnosis

Sponsors

Neurozentrum der Universitätsklinik Freiburg Abteilung Neuroradiologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients older than 18 years of age with suspicion of a brain tumor, who are able to give written consent. Presentation of written for the genetic analysis the brain tumour tissue sample.

Exclusion criteria

Exclusion criteria: Contraindications against gadolinium contrast-enhancement or MRI. Age 99 years.

Design outcomes

Primary

MeasureTime frame
Identification of imaging data that can be used for genetic classification within an algorithm.

Secondary

MeasureTime frame
Application of the developed algorithm to verify the quality of prediction of tumors.

Countries

Germany

Contacts

Public ContactPamela Heiland

Neurozentrum der Universitätsklinik Freiburg Abteilung Neurochirurgie

pamela.heiland@uniklinik-freiburg.de0761 270 50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026